DISCOVERY OF NOVEL KINASE INHIBITORS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Toffanin, S. [1 ,2 ]
Cabellos, L. [1 ]
Dong, H. [1 ]
Alsinet, C. [3 ]
Harrington, A. [1 ]
Cornella, H. [3 ]
Reddy, R. V. [4 ]
Reddy, P. M. [4 ]
Llovet, J. M. [1 ,3 ,5 ]
机构：
[1] Mt Sinai Sch Med, Div Liver Dis, Liver Canc Program, New York, NY USA
[2] Fdn IRCCS, Ist Nazl Tumori, Dept Surg & Expt Oncol, Hepatooncol Grp, Milan, Italy
[3] Univ Barcelona, Ctr Invest Biomed Red Enfermedades Hepat & Digest, HCC Translat Res Lab,Hosp Clin,IDIBAPS, Barcelona Clin Liver Canc Grp BCLC,Liver Unit, Barcelona, Spain
[4] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA
[5] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)61093-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1092
引用
收藏
页码：S446 / S447
页数：2
相关论文
共 50 条
  • [1] Novel Thienyl-Based Tyrosine Kinase Inhibitors for the Treatment of Hepatocellular Carcinoma
    Ma, Andi
    Biersack, Bernhard
    Goehringer, Nils
    Nitzsche, Bianca
    Hoepfner, Michael
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (05):
  • [2] Emerging tyrosine kinase inhibitors for the treatment of hepatocellular carcinoma
    de Rosamel, Laure
    Blanc, Jean-Frederic
    EXPERT OPINION ON EMERGING DRUGS, 2017, 22 (02) : 175 - 190
  • [3] Tyrosine kinase inhibitors: A potential approach to the treatment of hepatocellular carcinoma
    Giannelli, G.
    Napoli, N.
    Antonaci, S.
    CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (32) : 3301 - 3304
  • [4] Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
    Jiang, Lei
    Li, Luan
    Liu, Yongzhuang
    Lu, Ligong
    Zhan, Meixiao
    Yuan, Shengtao
    Liu, Yanyan
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [5] Development of novel epigenetic inhibitors for the treatment of hepatocellular carcinoma
    Barcena-Varela, M.
    Oyarzabal, J.
    Banales, J. M.
    Prieto, J.
    Alvarez-Asiain, L.
    Prosper, F.
    Berasain, C.
    Avila, M. A.
    Fernandez-Barrena, M. G.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S76 - S77
  • [6] Screening of Novel Kinase Inhibitors Identifies ARK5 as a Novel Therapeutic Target for the Treatment of Hepatocellular Carcinoma
    Toffanin, Sara
    Cabellos, Laia
    Alsinet, Clara
    Harrington, Andrew N.
    Cornella, Helena
    Reddy, M. V. Ramana
    Reddy, E. Premkumar
    Llovet, Josep M.
    HEPATOLOGY, 2012, 56 : 622A - 623A
  • [7] Discovery of potent and novel dual NAMPT/BRD4 inhibitors for efficient treatment of hepatocellular carcinoma
    Yin, Chunjia
    Jia, Shuting
    Yang, Xiaojuan
    Wu, Liqiang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 271
  • [8] Tyrosine Kinase Inhibitors and Hepatocellular Carcinoma
    da Fonseca, Leonardo G.
    Reig, Maria
    Bruix, Jordi
    CLINICS IN LIVER DISEASE, 2020, 24 (04) : 719 - 737
  • [9] Transarterial chemoembolization, ablation, tyrosine kinase inhibitors, and immunotherapy (TATI): A novel treatment for patients with advanced hepatocellular carcinoma
    Meng, Min
    Li, Wenhong
    Yang, Xia
    Huang, Guanghui
    Wei, Zhigang
    Ni, Yang
    Han, Xiaoying
    Wang, Jiao
    Ye, Xin
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (02) : 327 - 334
  • [10] Novel inhibitors in development for hepatocellular carcinoma
    Woerns, Marcus Alexander
    Galle, Peter Robert
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (05) : 615 - 629
12345